440 Investment Group’s AbbVie ABBV Stock Holding History

440 Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,317	Closed	-$216K	–	82
2017 Q1	$216K	Buy	+3,317	New	+$209K	0.19%	74

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

440 Investment Group's ABBV Position: Q2 2017 in Review

440 Investment Group sold out of AbbVie (ABBV) in Q2 2017, closing a stake of 3,317 shares — an estimated $216K sold.

440 Investment Group first reported a position in ABBV in Q1 2017 and held it in 1 quarter. The position peaked at $216K in Q1 2017. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

440 Investment Group reported no remaining AbbVie position as of Q2 2017 after selling out during the quarter.
440 Investment Group sold 3,317 AbbVie shares in Q2 2017, an estimated $216K.
440 Investment Group first reported a position in AbbVie in Q1 2017 and held it in 1 quarter.
440 Investment Group's AbbVie position peaked at $216K in Q1 2017.
1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on 440 Investment Group's 13F filing for Q2 2017, filed 2 Aug 2017.